CTDSPL2P2

Across TCGA pan-cancer cohorts, CTDSPL2P2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CTDSPL2P2 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher CTDSPL2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CTDSPL2P2 expression acts as an unfavorable survival marker.

BRCA, UCS, and LUSC are the cancer types where CTDSPL2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.768	0.925	<.001	72	view →
UCS	DFS	Tertile	All	0.134	0.530	.001	54	view →
LUSC	OS	Tertile	II,III,IV	0.228	0.618	.016	54	view →
LGG	DFS	Tertile	All	0.218	0.739	<.001	30	view →
KIRP	OS	Tertile	III,IV	0.176	0.661	.027	27	view →
STAD	OS	Tertile	All	0.103	0.541	.010	27	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	27	view →
GBM	OS	Tertile	All	0.075	0.413	.003	18	view →
LIHC	OS	Tertile	III,IV	0.093	0.615	<.001	18	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
KIRC	DFS	Tertile	All	0.336	0.638	.006	12	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CTDSPL2P2–BRCA (OS)

Open the BRCA breakdown →